National institute of health (NIH), national cancer institute (NCI), T veterinary clinical trial study to test combination anti-cancer therapy for dogs with naturally occurring melanoma S4 MSC to# 176…

Ended Awarded Last action

Contract number
75N98022F00064
Awardee
Awarding agency
Obligated
$182,825

Award facts

Contract value 55% obligated
  • $182,824.70 Current, with exercised options
  • $334,395.10 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Collins, CO 80523, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $31,254
Supplemental Agreement for work within scope P00002 $0
Change Order P00001 $0
Original award $151,570

About this award

This federal contract award from the National Institutes of Health (NIH), National Cancer Institute (NCI), is for a Veterinary Clinical Trial Study to Test Combination Anti-Cancer Therapy for Dogs with Naturally Occurring Melanoma. The $334,395.10 firm-fixed-price delivery order was awarded to Guidehouse Digital LLC, a global consulting firm that provides specialized scientific, technical, and administrative support services to federal agencies. The contract has a completion date of March 24, 2026 and was not set aside for any specific business category. Guidehouse Digital LLC has demonstrated expertise in supporting clinical research, laboratory management, data analysis, and scientific computing for agencies like NIH, which aligns with the requirements of this veterinary oncology study. The contract is funded by the NIH/NCI and is part of the agency's broader efforts to develop new cancer treatment approaches for both human and animal patients.

Description

National institute of health (NIH), national cancer institute (NCI), T veterinary clinical trial study to test combination anti-cancer therapy for dogs with naturally occurring melanoma S4 MSC to# 176 NCI/CCR/lcbg

Quick answers

Who was awarded contract 75N98022F00064?

75N98022F00064 was awarded to Guidehouse Digital LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 5, 2022.

How much is contract 75N98022F00064 worth?

The government has obligated $182,825 on 75N98022F00064. Its potential value, with all options, is $334,395.

Is contract 75N98022F00064 an order under another contract?

Yes. 75N98022F00064 is a delivery order under 75N98020D00086, an indefinite delivery contract.

Was contract 75N98022F00064 competed?

The extent of competition for 75N98022F00064 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award